Our Team

Senior-level executives with extensive backgrounds in investment banking, life sciences, medicine, and operating executives from various industries.

Ben Perkins

Managing Partner

Erik Halvorsen, Ph.D.

Partner

Adam Harrington

Partner

Scott Snow

Director
Keenan McCollom

Peder Hatling

Principal
Keenan McCollom

Keenan McCollom

Partner

Brad Johnson

Vice President
Jamie Kline

Jamie Kline

Vice President of Operations
Jamie Kline

Justin Luker

Associate
Jamie Kline

Paul Maiellano

Associate

Geraldine Schott, Ph.D.

Associate
Keenan McCollom

Yash Erukulla

Analyst
Keenan McCollom

Jackson Savage

Analyst

About pH Partners

 

pH Partners, LLC (“pHp”) is a boutique investment banking firm delivering capital formation, partnership, merger, and acquisition solutions to companies at the convergence of Healthcare, Technology, and the Consumer. Our partners have collectively closed over $20B in strategic advisory transactions and raised more than $15B in capital for our clients. pHp is headquartered in Austin, Texas with offices in Houston, Portland, and New York.

The pH Partners team consists of senior-level executives with extensive backgrounds in investment banking, life sciences, medicine, and operating executives from various industries. Through this combination of operations and transaction expertise, our partners have decades of experience navigating the unique pressures a transaction creates within a business. pH works closely with management teams to clearly understand each unique situation and provide expertly tailored strategies to maximize outcomes for our clients.

Our leaders have decades of experience and significant US and cross-border advisory experience leveraging a premier international network to serve a global client base. At pH Partners we work to provide our clients with quality service and attention so together we can achieve the best outcome possible.

Through our subsidiary, pH Capital Partners, we offer flexible capital solutions acting as a lead investor or in partnership with other institutional capital.